Alembic Ltd
Pharmaceuticals & Biotechnology | Small Cap
Alembic Ltd, a real estate company, shows a mixed financial performance. The company demonstrates strong solvency and coverage ratios. Growth ratios are also robust, driven by significant increases in operating profit, EPS, asset, and net income. However, liquidity ratios are poor, indicating potential difficulties in meeting short-term obligations. Efficiency ratios are also low, suggesting ineffective asset utilization. While profitability metrics like ROCE and ROE are strong, others such as gross profit margin and operating margin are weak, resulting in an average profitability score. Financial ratios are also average due to moderate adjusted EPS, cash EPS, book value per share and dividend per share. Overall, Alembic Ltd exhibits strengths in long-term financial health and growth, but faces challenges in short-term liquidity and operational efficiency.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsUndervalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.00
- Financial Ratio6.20
- Profitability Ratio5.60
- Efficiency Ratio4.67
- Coverage Ratio10.00
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayBullish
- 1 WeekNeutral
- 1 MonthBearish
Alembic Ltd, a real estate company, shows a mixed financial performance. The company demonstrates strong solvency and coverage ratios. Growth ratios are also robust, driven by significant increases in operating profit, EPS, asset, and net income. However, liquidity ratios are poor, indicating potential difficulties in meeting short-term obligations. Efficiency ratios are also low, suggesting ineffective asset utilization. While profitability metrics like ROCE and ROE are strong, others such as gross profit margin and operating margin are weak, resulting in an average profitability score. Financial ratios are also average due to moderate adjusted EPS, cash EPS, book value per share and dividend per share. Overall, Alembic Ltd exhibits strengths in long-term financial health and growth, but faces challenges in short-term liquidity and operational efficiency.
Overall Valuation Score
P/E RATIO (TTM)
18.55
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
7.28
P/B RATIO
0.95
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
9.55
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
-4.67
EV/EBITDA RATIO
14.08
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹89.98 as on Jun 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company demonstrates robust growth, driven by strong increases in operating profit, EPS, asset base and net income. This growth trajectory indicates effective strategic initiatives and market positioning. While revenue growth is still low, the positive trends in profit and asset growth highlight the company's potential for sustained expansion. Continuing to capitalize on these growth drivers is essential for enhancing long-term shareholder value.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 5.41 | 62.82 | 23.62 | 41.4 | 8.11 |
| Operating Profit Growth Rate | 27.27 | 185.71 | 42.5 | 64.91 | -4.26 |
| Earnings Per Share (EPS) Growth | -35.21 | -14.22 | 40.97 | 15.68 | 2.15 |
| Asset Growth Rate | 9.26 | -16.22 | 5.62 | 7.47 | 3.48 |
| Net Income Growth Rate | -35.28 | -13.96 | 40.84 | 15.61 | 1.93 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios present a mixed picture. While capital expenditure is well-managed, adjusted EPS, cash EPS, book value per share, and dividend per share are moderate. This suggests a need for improvements in earnings quality and shareholder returns. Strategic initiatives to enhance profitability and capital allocation can improve overall financial performance.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 8.59 | 7.8 | 10.51 | 12.16 | 12.43 |
| Cash Earnings Per Share (Cash EPS) | 8.9 | 7.76 | 10.86 | 12.63 | 12.9 |
| Book Value Per Share | 97.88 | 81.49 | 85.69 | 91.69 | 95.88 |
| Dividend Per Share (DPS) | 1.82 | 2.23 | 2.41 | 2.42 | 2.35 |
| Capital Expenditures (CapEx) | 34 | 25 | 56 | 51 | 77 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability ratios present a mixed picture. While ROCE and ROE are strong, gross profit margin, return on assets, operating margin, and net margin are weak. This indicates the company is effective at generating profits from its capital and equity but struggles with overall profitability. Improving cost management and operational efficiency can enhance overall profitability.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 11.54 | 25.98 | 31.21 | 37.39 | 32.5 |
| Return on Capital Employed (ROCE) | 4 | 4 | 5 | 7 | 6 |
| Return on Equity (ROE) | 8.89 | 9.19 | 12.31 | 13.3 | 12.97 |
| Return on Assets (ROA) | 0.53 | 1.81 | 2.45 | 3.76 | 3.47 |
| Operating Margin | 17.95 | 31.5 | 36.31 | 42.34 | 37.5 |
| Net Margin | 284.62 | 150.39 | 171.34 | 140.09 | 132.08 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency ratios present a mixed outlook. While receivable days and days sales in inventory are well-managed, the turnover ratios for fixed assets, inventory, receivables, and capital are low. This might indicate effective inventory and receivables management but also suggests underutilization of assets in generating revenue. Improving asset utilization and operational processes may enhance overall efficiency and profitability.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 0.26 | 0.4 | 0.43 | 0.54 | 0.51 |
| Inventory Turnover Ratio | 0.98 | 1.07 | 1.2 | 1.45 | 2.15 |
| Receivables Turnover Ratio | 5.38 | 6.68 | 7.3 | 8.88 | 7.74 |
| Days Sales in Inventory Ratio | 372.45 | 341.12 | 304.17 | 251.72 | 169.77 |
| Receivable Days | 67.84 | 54.64 | 50 | 41.1 | 47.16 |
| Capital Turnover Ratio | 0.03 | 0.06 | 0.07 | 0.09 | 0.1 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company exhibits strong coverage ratios, indicating a robust capacity to meet its interest and dividend obligations. This financial stability reassures investors and creditors, reflecting low financial risk. The high interest coverage ratio suggests the company can comfortably handle its debt obligations, while the strong equity dividend coverage supports consistent dividend payouts to shareholders. Maintaining these coverage levels is crucial for sustaining investor confidence and financial health.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | N/A | N/A | 104 | 79 | 75.5 |
| Equity Dividend Coverage Ratio | 4.76 | 3.33 | 4.35 | 5 | 5.26 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits strong solvency due to minimal debt and a high equity base, suggesting a stable financial structure. The high equity ratio indicates a lower risk of financial distress and greater capacity to absorb losses. This financial stability allows the company to pursue long-term growth opportunities and strategic investments with less concern about debt obligations. However, it may also reflect a missed opportunity to leverage debt for higher returns, as prudent use of debt can sometimes enhance profitability.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to Equity Ratio | 0 | 0 | 0 | 0 | 0 |
| Equity Ratio | 1 | 1 | 1 | 1 | 1 |
| Debt To Asset Ratio | 0 | 0 | 0 | 0 | 0 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position raises concerns, as all key metrics indicate poor short-term financial health. While a lower liquidity position might free up cash for reinvestment, the company may face challenges in meeting its immediate liabilities. Given the cyclical nature of the real estate industry, maintaining adequate liquidity is essential to weather economic downturns and sustain operations. The company needs to improve its short-term asset management and cash flow strategies to enhance its ability to meet its obligations promptly.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 0.94 | 1.02 | 1.27 | 1.26 | 1.03 |
| Quick Ratio | 0.3 | 0.32 | 0.59 | 0.62 | 0.65 |
| Cash Ratio | 0.01 | 0.02 | 0.01 | 0.03 | 0.02 |
| Operating Cash Flow Ratio | -0.13 | 0.31 | 0.17 | 0.56 | 0.87 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jagsonpal Pharmaceuticals Ltd | 8.51 | 33.01 | Overvalued | 58.00 | 6.42 | 43.00 |
| 2 | Amrutanjan Health Care Ltd | 8.25 | 77.37 | Highly Overvalued | 31.00 | 20.03 | 21.00 |
| 3 | Windlas Biotech Ltd | 7.52 | 25.92 | Neutral | 105.00 | 32.19 | 66.00 |
| 4 | Lincoln Pharmaceuticals Ltd | 7.31 | 14.01 | Neutral | 98.00 | 43.88 | 88.00 |
| 5 | RPG Life Sciences Ltd | 7.12 | 32.70 | Neutral | 147.00 | 69.64 | 115.00 |
| 6 | Morepen Laboratories Ltd | 7.12 | 28.61 | Neutral | 126.00 | 1.21 | 96.00 |
| 7 | Alembic Ltd | 7.06 | 7.28 | Undervalued | 90.00 | 4.85 | 317.00 |
| 8 | Syncom Formulations (India) Ltd | 6.92 | 17.27 | Undervalued | 77.00 | 0.81 | 76.00 |
| 9 | Hester Biosciences Ltd | 6.54 | 31.74 | Neutral | 87.00 | 61.24 | 57.00 |
| 10 | Sigachi Industries Ltd | 6.49 | 11.55 | Highly Undervalued | 54.00 | -2.08 | -83.00 |
| 11 | SMS Pharmaceuticals Ltd | 5.94 | 34.77 | Neutral | 171.00 | 9.35 | 102.00 |
| 12 | Gufic BioSciences Ltd | 5.49 | 55.51 | Neutral | 151.00 | 6.30 | 64.00 |
| 13 | Dishman Carbogen Amcis Ltd | 5.38 | 27.45 | Neutral | 566.00 | -2.45 | 97.00 |
| 14 | IOL Chemicals & Pharmaceuticals Ltd | 5.31 | 27.76 | Undervalued | 269.00 | 4.69 | 138.00 |
| 15 | Indoco Remedies Ltd | 5.26 | -22.79 | Neutral | 142.00 | -0.61 | -99.00 |
| 16 | Aarti Drugs Ltd | 5.07 | 17.34 | Undervalued | 309.00 | 18.54 | 195.00 |
| 17 | Solara Active Pharma Sciences Ltd | 4.34 | -274.68 | Neutral | 187.00 | -1.50 | -7.00 |
Alembic Ltd.'s management effectiveness is a mixed bag. Strong sales growth and improving operating profit margins showcase operational capabilities. However, inconsistent profit growth and a high cash conversion cycle raise concerns. The consistently high promoter holding signals confidence, while declining DII holdings could reflect changing institutional perspectives.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth (TTM) | 41% | Robust revenue expansion |
| OPM Improvement (Latest Year) | 42% | Enhancing operational efficiency | |
| Promoter Holding | 70.88% | High promoter confidence | |
| CONS | Profit Growth Inconsistency | -1% (5Y CAGR) | Fluctuating profitability trends |
| Cash Conversion Cycle | 425 Days | Extended working capital cycle | |
| Declining DII Holding | 0.05% | Potential shift in institutional sentiment |
Financial Performance & Growth
Alembic Ltd. exhibits strong sales growth alongside inconsistent profit growth. Compounded sales growth has been robust recently, with a TTM of 41%. However, the compounded profit growth over 5 years is -1%, indicating difficulty in consistently translating sales into profits. Quarterly sales have generally increased, but profit variations have been significant.
| Metric | 2015-2017 | 2018-2020 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 142 | 91 | 127 | 157 | 222 |
| Profit (₹ Cr) | 194 | 295 | 191 | 269 | 311 |
Capital Efficiency & Returns
ROCE and ROE show mixed signals regarding capital efficiency. ROCE has fluctuated, with the latest figure at 7%. The cash conversion cycle is high, indicating inefficient working capital management.
| Metric | Mar 2016 | Mar 2017 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| ROCE (%) | 4% | 4% | 4% | 5% | 7% |
| Cash Conversion Cycle (Days) | 591 | 364 | 67 | 2,502 | 425 |
Financial Health & Prudence
Alembic Ltd. maintains a healthy financial profile with minimal debt as borrowings are relatively low. The company has been consistently sharing profits through dividends, with a dividend payout of 20% in the most recent year.
| Metric | 2010–2017 | 2018–2025 |
|---|---|---|
| Average Borrowings (₹ Cr) | 85.28 | 5.25 |
| Average Dividend Payout (%) | 12.12 | 18.75 |
Shareholding & Ownership Structure
The shareholding pattern indicates high promoter confidence with a consistently high holding of 70.88%. However, there has been a decrease in DII holding over the years. FII holding has fluctuated, indicating varying levels of interest from foreign institutional investors.
| Metric | Mar 2017 | Mar 2021 | Mar 2025 |
|---|---|---|---|
| Promoter Holding (%) | 65.77 | 70.88 | 70.88 |
| FII Holding (%) | 5.60 | 1.60 | 1.65 |
| DII Holding (%) | 0.09 | 4.34 | 0.05 |
Alembic Ltd. faces moderate risk due to segment performance volatility and a high cash conversion cycle. These factors, combined with inconsistent profit growth, contribute to the risk assessment, indicating areas of concern that investors should be aware of.
Accounting quality red flags
Based on the data provided, the financial statements appear consistent, and there are no significant anomalies in the reported figures.
Segment performance volatility
Segment performance volatility is evident in Alembic Ltd.'s quarterly results. The YOY Sales Growth % shows significant fluctuations, ranging from -13.74% to 103.51%. This variability indicates potential inconsistencies in segment performance.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1091.78Bearish
- SMA 2091.72Bearish
- SMA 5089.32Bullish
- EMA 1091.14Bearish
- EMA 2091.17Bearish
- EMA 5089.94Bullish
- DEMA 1090.54Bearish
- DEMA 2091.77Bearish
- DEMA 5091.62Bearish
- TEMA 1089.75Bullish
- TEMA 2091.14Bearish
- TEMA 5092.52Bearish
- MACD0.29Bearish
- ADX43.10Strong Trend
- IndicatorValueSignal
- RSI44.57Neutral
- CCI-72.01Neutral
- ROC 9-3.36Bearish
- ROC 14-0.34Bearish
- ROC 251.35Bullish
- Stoch K11.13Oversold
- Stoch D11.85Oversold
- IndicatorValueSignal
- BB Upper95.10Neutral
- BB Middle91.72Neutral
- BB Lower88.34Neutral
- ATR1.04Low Volatility
- IndicatorValueSignal
- MFI28.11Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1091.91Bearish
- SMA 2090.66Bearish
- SMA 5088.06Bullish
- EMA 1091.17Bearish
- EMA 2090.48Bearish
- EMA 5089.07Bullish
- DEMA 1091.48Bearish
- DEMA 2091.93Bearish
- DEMA 5090.15Bullish
- TEMA 1090.78Bearish
- TEMA 2092.16Bearish
- TEMA 5091.48Bearish
- MACD1.02Bearish
- ADX32.37Strong Trend
- IndicatorValueSignal
- RSI51.26Neutral
- CCI-32.37Neutral
- ROC 9-0.51Bearish
- ROC 141.65Bullish
- ROC 255.74Bullish
- Stoch K22.57Neutral
- Stoch D37.95Neutral
- IndicatorValueSignal
- BB Upper94.10Neutral
- BB Middle90.66Neutral
- BB Lower87.21Neutral
- ATR1.37Low Volatility
- IndicatorValueSignal
- MFI29.63Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1090.49Bearish
- SMA 2088.46Bullish
- SMA 5087.93Bullish
- EMA 1090.30Bearish
- EMA 2089.25Bullish
- EMA 5088.46Bullish
- DEMA 1091.56Bearish
- DEMA 2090.54Bearish
- DEMA 5089.13Bullish
- TEMA 1091.71Bearish
- TEMA 2091.69Bearish
- TEMA 50N/AN/A
- MACD1.09Bullish
- ADX20.77Weak Trend
- IndicatorValueSignal
- RSI55.33Neutral
- CCI53.03Neutral
- ROC 90.76Bullish
- ROC 144.88Bullish
- ROC 255.34Bullish
- Stoch K60.31Neutral
- Stoch D70.85Neutral
- IndicatorValueSignal
- BB Upper93.22Neutral
- BB Middle88.46Neutral
- BB Lower83.71Neutral
- ATR1.90Low Volatility
- IndicatorValueSignal
- MFI39.54Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1088.42Bullish
- SMA 2087.75Bullish
- SMA 5089.39Bullish
- SMA 10088.85Bullish
- SMA 20094.87Bearish
- EMA 1089.29Bullish
- EMA 2088.67Bullish
- EMA 5088.62Bullish
- EMA 10090.19Bearish
- EMA 20094.61Bearish
- DEMA 1090.55Bearish
- DEMA 2089.06Bullish
- DEMA 5087.96Bullish
- DEMA 10086.00Bullish
- DEMA 20086.54Bullish
- TEMA 1091.61Bearish
- TEMA 2089.66Bullish
- TEMA 5089.19Bullish
- TEMA 10087.08Bullish
- TEMA 20083.66Bullish
- MACD0.47Bullish
- ADX15.55Weak Trend
- IndicatorValueSignal
- RSI53.76Neutral
- CCI147.52Overbought
- ROC 143.84Bullish
- ROC 25-1.49Bearish
- Stoch K73.65Neutral
- Stoch D79.68Neutral
- IndicatorValueSignal
- BB Upper91.69Neutral
- BB Middle87.75Neutral
- BB Lower83.81Neutral
- ATR2.69High Volatility
- IndicatorValueSignal
- MFI51.27Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2088.28Bearish
- SMA 5097.55Bearish
- EMA 2089.72Bearish
- EMA 5095.75Bearish
- DEMA 2085.96Bullish
- DEMA 5087.79Bearish
- TEMA 2086.94Bullish
- TEMA 5083.16Bullish
- MACD-2.55Bullish
- ADX14.02Weak Trend
- IndicatorValueSignal
- RSI43.57Neutral
- CCI-92.46Neutral
- ROC 14-0.10Bearish
- ROC 25-12.84Bearish
- Stoch K64.89Neutral
- Stoch D64.76Neutral
- IndicatorValueSignal
- BB Upper99.91Neutral
- BB Middle88.28Neutral
- BB Lower76.66Neutral
- ATR5.67Low Volatility
- IndicatorValueSignal
- MFI31.84Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 689.26Bearish
- SMA 1297.52Bearish
- SMA 24109.70Bearish
- EMA 689.54Bearish
- EMA 1294.84Bearish
- EMA 2498.64Bearish
- DEMA 684.68Bullish
- DEMA 1287.22Bullish
- DEMA 2497.48Bearish
- TEMA 685.15Bullish
- TEMA 1282.51Bullish
- TEMA 2490.00Bearish
- MACD3.94Bearish
- ADX13.78Weak Trend
- IndicatorValueSignal
- RSI48.87Neutral
- CCI-12.18Neutral
- ROC 25-5.46Bearish
- ROC 5020.97Bullish
- Stoch K23.32Neutral
- Stoch D42.22Neutral
- IndicatorValueSignal
- BB Upper134.95Neutral
- BB Middle103.96Neutral
- BB Lower72.97Neutral
- ATR17.15Low Volatility
- IndicatorValueSignal
- MFI65.22Neutral